Driehaus Capital Management LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 938206 Chicago, IL

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$192,123,952

+$51,068,779 QoQ

Shares Held

4,728,623

+5.6% QoQ

Ownership

4.35%

of shares outstanding

% of Portfolio

1.12%

of 13F equity value

Holder Rank

of 223 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 82% Shared 0% None 18%

Healthcare · as of Jun 30, 2026

Driehaus Capital Management LLC holds $3,602,052,293 across 59 Biotechnology names. EWTX ranks #7 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DFTX	Definium Therapeutics, Inc.	6,845,276	$322,001,783
2	PRAX	Praxis Precision Medicines, Inc.	959,048	$321,079,679
3	XENE	Xenon Pharmaceuticals Inc.	4,418,557	$266,704,100
4	SYRE	Spyre Therapeutics, Inc.	2,799,166	$248,509,957
5	CRNX	Crinetics Pharmaceuticals, Inc.	6,463,551	$241,866,078
6	APGE	Apogee Therapeutics, Inc.	1,740,101	$230,963,605
7	EWTX	Edgewise Therapeutics, Inc. This page	4,728,623	$192,123,952
8	SEPN	Septerna, Inc.	4,433,058	$148,463,112

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$192,123,952	4,728,623	+5.6%	Shares	Sole	2026-08-14
2026-03-31	$141,055,173	4,477,942	+6.8%	Shares	Sole	2026-05-15
2025-12-31	$104,004,454	4,191,193	+88.1%	Shares	Sole	2026-02-17
2025-09-30	$36,142,782	2,228,285	+6.0%	Shares	Sole	2025-11-14
2025-06-30	$27,554,348	2,101,781	+52.8%	Shares	Sole	2025-08-14
2025-03-31	$30,266,324	1,375,742	-7.9%	Shares	Sole	2025-05-15
2024-12-31	$39,884,219	1,493,791	-23.5%	Shares	Sole	2025-02-14
2024-09-30	$52,136,886	1,953,424	+55.0%	Shares	Sole	2024-11-14
2024-06-30	$22,699,659	1,260,392	-0.6%	Shares	Sole	2024-08-15
2024-03-31	$23,125,018	1,267,819	+220.9%	Shares	Sole	2024-05-15
2023-12-31	$4,322,054	395,069	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.